Perelman School of Medicine

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653February 23, 2015

Penn Medicine Physician Finds No Preventive Benefits for Widely Used Kidney Cancer Drugs

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the U

New Screening Tests for Hard-to-spot Breast Cancers

February 24, 2015

Emily Conant of the Perelman School of Medicine is quoted about testing for breast cancer and the legislation in some s

Article Source: Wall Street Journal

Scheie Eye Institute to Study Genetic Factors of Glaucoma in Blacks

February 23, 2015

Joan O’Brien of the Perelman School of Medicine discusses leading a study about the genetics of glaucoma in African Ame

Article Source: Philadelphia Tribune

Does Your Physician Have to Prescribe Antibiotics for Every Sore Throat?

February 23, 2015

Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School co-authors an article sharing his thoughts on

Article Source: Fortune.com

Teens Need to Understand How Their Brains Work

February 23, 2015

Frances Jensen of the Perelman School of Medicine writes about the importance of teenagers learning about how their bra

Article Source: Philly.com

Audio: Modified Immune Cells Show Promise in Treating Brain Cancer, Penn Scientists Find

February 19, 2015

Marcela Maus of the Perelman School of Medicine comments on a study about a personalized immune therapy that redirects

Most Women Should Expect Seven Years of Hot Flashes, Longer for African-Americans

February 17, 2015

Ellen Freeman of the Perelman School of Medicine discusses menopause and hot flashes.

facebook twitter google print email
Media Contact:Karen Kreeger | karen.kreeger@uphs.upenn.edu | 215-349-5658February 19, 2015

Eczema Medication Unlikely to Increase Risk of Cancer in Children, Penn Team Finds

The topical eczema medicine pimecrolimus appears unlikely to be associated with an increased risk of cancer in children, based on a group of children who were followed for 10 years, 

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659February 18, 2015

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Scienc

Molecule Shows Ability to Block AIDS Virus

February 18, 2015

Philip Johnson of the Perelman School of Medicine is quoted about a new molecule that can block infection with the virus that causes AIDS. 

Article Source: Wall Street Journal